Private-equity firm Hildred Capital Management has closed its first continuation fund to extend its ownership of two consumer-healthcare businesses and inject them with more money for growth. The fund closed at its upper limit of $750 million, with about 20% of the capital coming from investors that already held stakes in the companies and rolled those stakes into the new vehicle, said Andrew Goldman, Hildred’s co-founder and managing partner. The money enables Hildred to continue its ownership of portfolio companies Crown Laboratories, which makes skin-care products, and Hyland’s Naturals, which makes natural vitamins and minerals and over-the-counter medications, particularly for children.
Read the full article: Hildred Capital Raises $750M Continuation Fund //
Source: https://www.wsj.com/articles/hildred-capital-raises-750-million-continuation-fund-b2bb7b92